William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 53,626 shares at $8.28 ($444K) on 2022-01-05, disclosed to the SEC on 2022-01-07.
Open-market sale of $444k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.28 | 26,813 | $222K | 50.0% |
| 2 | $8.28 | 26,813 | $222K | 50.0% |
| Total | $8.28 avg | 53,626 | $444K | 100% |
| Filing → |
| IMVT | SELL | 2024-11-22 | $171K | — | Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |